Close
Solutions
Online Inquiry
Global Services

CAR-T Cell Line Characterization

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

As a leading cell therapy biotechnology company, Creative Biolabs provides one-stop CAR-T therapy development services, ranging from GMP/GLP-graded CAR plasmid production (providing mg-level to g-level production scale), GMP-graded CAR lentivirus production, to CAR -T cell production to meet the needs of non-clinical research and clinical phase I trials initiated by cellular therapy researchers.

Understanding each step of the CAR-T workflow is essential to ensure the quality and effectiveness of the final CAR-T product. An Ideally panel for new CAR-T development and QC, the CAR-T generation cell line characterization panel can help simplify the CAR-T manufacturing workflow and potentially reduce vein to vein time. Besides, contaminant-free cell banks lay a solid foundation for you to maintain a stable production path in the next few years. Therefore, proper cell line characterization is critical to confirm the certainty of the contamination-free cell bank. Creative Biolabs offers a wide range of CAR-T cell line characterization services, including phenotypic or genotypic identity testing, which is required for mammalian, microbial, and insect cell substrate testing to generate CAR-T cells.

Overview of our Cell Line Characterization Package

The characterization of CAR-T cell lines mainly involves the following cell lines:

  • CAR plasmid manufacturing cell line. Generally, bacteria or fungal cell lines are used to prepare GMP-grade plasmids through large-scale fermentation.
  • CAR lentivirus manufacturing cell line. By transfecting CAR lentivirus to 293T cell line to prepare cGMP grade bulk virus.
  • CAR-T cell manufacturing cell line. Usually, human autologous T cells or Jurkat cell lines, which are stable cell lines developed by transducing CAR lentivirus.

More specifically, the characterization of CAR-T cell lines is to perform cell lines on the main cell bank (MCB), working cell bank (WCB) used for production. According to current regulations, the following aspects must be considered:

  • Origin and history of cell morphology and growth characteristics of cell lines
  • Cell identity
  • The purity of the cell line (ie, non-contaminated cells, microbial contamination, and adventitious virus contamination)
  • Tumorigenicity and carcinogenicity
  • Stability

When executing the assays, Creative Biolabs follows the guidelines recommend and using testing procedures that are validated to show their suitability for intended CAR-T purpose.

Advanced Analysis Modules Available for CAR-T Cell Line Characterization

The following table lists the recommended test panels for characterizing general mammalian and microbial cell lines used to produce CAR-T, as well as T cells.

Microbial Cell Line Characterization Panel

Recommended Testing Items MCB WCB
Bacteriophage detection + +
Purity + +
Identification + +
Viability + +
Copy number + +
DNA Sequencing + +
Retention of selectable markers + +
Retention of recombinant construct + +
Restriction Endonuclease Analysis + +

Mammalian Cell line Characterization Panel

Recommended Testing Items MCB WCB EPC/CAL
Microbial Contamination Sterility + + +
Mycoplasma + + +
Mycobacterium +
Spiroplasma +
Cell Line Identity DNA Barcoding + + +
DNA fingerprinting/STR + +
Karyology + +
Genetic stability DNA sequencing + Optional
Gene copy number by qPCR/STR + +
Virus Testing Retroviruses: Reverse transcriptase and retroviral infectivity assays + +
In vitro adventitious viruses + + +
In vivo adventitious viruses + +
Test for specific viruses such as:
Bovine viruses
Porcine viruses
Human viruses
Minute virus of mice
+
In vivo biosafety: Mouse, hamster, and rat antibody production assays (MAP, RAP, and HAP) +
Transmission electron microscopy + +
Tumorigenicity/Oncogenicity +

T Cell line Characterization Panel

Recommended Testing Items MCB WCB EPC/CAL
Microbial Contamination Sterility + + +
Mycoplasma + + +
SV40 Large T Antigen Sequence Analysis + + +
Cell Line Identity DNA Barcoding + + +
Genetic stability DNA sequencing + +
Gene copy number + +
Restriction endonuclease analysis + +
Virus Testing Endogenous and non-endogenous retroviruses: reverse transcriptase and retroviral infectivity assays + +
In vitro adventitious viruses + +
In vivo adventitious viruses (suckling and adult mice, embryonated eggs) + +
Test for specific viruses such as:
Bovine viruses
Porcine viruses
Minute virus of mice
+
In vivo biosafety: Mouse and hamster antibody production assays (MAP and HAP) +
Transmission electron microscopy + +
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.